STRN4 and liver cancer: In order to investigate whether MAFG-AS1 affects the drug-resistant liver cancer cell lines by regulating the miR-3196/STRN4 pathway, we manipulated the expression of miR-3196 and STRN4 with miR-3196 inhibitor and sh-STRN4, respectively.